This inventor holds 42 USPTO granted patents, plus 1 CIPO patent, primarily in Pharmaceutical Chemistry. Top assignees: Schering Aktiengesellschaft, Berlex Laboratories, Inc.. Active years: 1977-2001.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1977-2001
Areas of Expertise:
Title: Helmut Wachtel: Innovator in Pharmaceutical Patents
Introduction
Helmut Wachtel is a prominent inventor based in Berlin, Germany, recognized for his significant contributions to the pharmaceutical field. With a remarkable portfolio comprising 42 patents, Wachtel's work has been instrumental in developing new therapeutic approaches for neurological and inflammatory diseases.
Latest Patents
Two of Wachtel's latest patents showcase his innovative approach to addressing critical healthcare challenges. The first patent focuses on the use of quisqualate receptor antagonists, presenting a groundbreaking method for utilizing antagonists of the AMPA receptor complex and their physiologically compatible salts. This invention targets the prevention and treatment of Parkinson's disease and highlights the pharmaceutical applications of these compounds. The second patent involves pharmaceutical preparations aimed at tumor necrosis factor (TNF) inhibition, indicating that specific compounds of formula I play a vital role in treating TNF-mediated diseases.
Career Highlights
Wachtel’s professional journey includes significant positions at notable companies in the pharmaceutical industry, such as Schering Aktiengesellschaft and Berlex Laboratories, Inc. His tenure at these organizations has allowed him to collaborate on various projects that enhance the understanding of drug development and improve therapeutic options for patients.
Collaborations
Throughout his impressive career, Wachtel has worked alongside esteemed colleagues, including Gerhard Sauer and Wolfgang Kehr. These collaborations have fostered innovative ideas and led to advancements in research that have positively impacted patient care and treatment outcomes.
Conclusion
Helmut Wachtel's dedication to innovation in pharmaceuticals is evidenced by his substantial number of patents, reflecting his commitment to addressing critical health issues. His research not only enhances the understanding of complex diseases but also establishes new pathways for effective treatments. Wachtel's contributions continue to inspire future generations of inventors in the field of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile